Paying users zone. Data is covered by 
.
Get to Abbott Laboratories for $17.99, or
get to whole website for at least 3 months from $49.99.
Common-Size Income Statement
Difficulty: Beginner
Abbott Laboratories, Common-Size Consolidated Income Statement
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | |
|
|
|
|
||||||
| Cost of products sold, excluding amortization of intangible assets | |
|
|
|
|
||||||
| Amortization of intangible assets | |
|
|
|
|
||||||
| Gross profit | |
|
|
|
|
||||||
| Research and development | |
|
|
|
|
||||||
| Selling, general and administrative | |
|
|
|
|
||||||
| Operating earnings | |
|
|
|
|
||||||
| Interest expense | |
|
|
|
|
||||||
| Interest income | |
|
|
|
|
||||||
| Net loss on extinguishment of debt | |
|
|
|
|
||||||
| Net foreign exchange gain (loss) | |
|
|
|
|
||||||
| Other income (expense), net | |
|
|
|
|
||||||
| Earnings from continuing operations before taxes | |
|
|
|
|
||||||
| Taxes on earnings from continuing operations | |
|
|
|
|
||||||
| Earnings from continuing operations | |
|
|
|
|
||||||
| Earnings from discontinued operations, net of taxes | |
|
|
|
|
||||||
| Gain on sale of discontinued operations, net of taxes | |
|
|
|
|
||||||
| Net earnings from discontinued operations, net of taxes | |
|
|
|
|
||||||
| Net earnings | |
|
|
|
|
Based on: 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21).
| Item | Description | The company |
|---|---|---|
| Operating earnings | The net result for the period of deducting operating expenses from operating revenues. | Abbott Laboratories's operating earnings as a percentage of net sales increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
| Earnings from continuing operations before taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Abbott Laboratories's earnings from continuing operations before taxes as a percentage of net sales declined from 2015 to 2016 but then slightly increased from 2016 to 2017. |
| Net earnings | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Abbott Laboratories's net earnings as a percentage of net sales declined from 2015 to 2016 and from 2016 to 2017. |
